These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17428931)

  • 21. [An update on antifungal susceptibility testing].
    Tapia P CV
    Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
    Pai MP; Jones AL
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4441-3. PubMed ID: 15504877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs.
    Pfaller MA; Messer SA; Boyken L; Hollis RJ; Diekema DJ
    Diagn Microbiol Infect Dis; 2003 Apr; 45(4):241-4. PubMed ID: 12729993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Colorimetric broth microdilution for antifungal susceptibility testing].
    Yamane N; Tosaka M; Okazawa Y
    Rinsho Byori; 1996 Jan; 44(1):67-75. PubMed ID: 8691643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal activity of organotin compounds with functionalized carboxylates evaluated by the microdilution bioassay in vitro.
    Dylag M; Pruchnik H; Pruchnik F; Majkowska-Skrobek G; Ułaszewski S
    Med Mycol; 2010 Mar; 48(2):373-83. PubMed ID: 19688632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
    Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
    J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Sensititre YeastOne
    Chang W; Bao F; Wang Z; Liu H; Zhang F
    Mycoses; 2021 Jul; 64(7):734-741. PubMed ID: 33760301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
    Chryssanthou E; Cuenca-Estrella M
    Clin Microbiol Infect; 2006 Sep; 12(9):901-4. PubMed ID: 16882296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of a dried commercially-prepared microdilution panel for antifungal susceptibility testing.
    Messer SA; Pfaller MA
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):77-81. PubMed ID: 8882893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates.
    Cuenca-Estrella M; Gomez-Lopez A; Alastruey-Izquierdo A; Bernal-Martinez L; Cuesta I; Buitrago MJ; Rodriguez-Tudela JL
    J Clin Microbiol; 2010 May; 48(5):1782-6. PubMed ID: 20220169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interlaboratory evaluation of VITEK2 system and Sensititre YeastOne® for antifungal susceptibility testing of yeasts isolated from blood cultures against four antifungal agents.
    Farina C; Manso E; Andreoni S; Conte M; Fazii P; Lombardi G; Sanna S; Russello G
    New Microbiol; 2011 Apr; 34(2):195-201. PubMed ID: 21617832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.
    Siopi M; Pournaras S; Meletiadis J
    J Clin Microbiol; 2017 Jun; 55(6):1714-1719. PubMed ID: 28330883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Fothergill A; Ghannoum M; Manavathu E; Ostrosky-Zeichner L; Pfaller M; Rinaldi M; Schell W; Walsh T
    J Clin Microbiol; 2005 Oct; 43(10):5243-6. PubMed ID: 16207990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal susceptibility testing method for resource constrained laboratories.
    Khan S; Singhal S; Mathur T; Upadhyay DJ; Rattan A
    Indian J Med Microbiol; 2006 Jul; 24(3):171-6. PubMed ID: 16912435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a glucose consumption based method with the CLSI M38-A method for testing antifungal susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes.
    Zhang J; Chen J; Huang HQ; Xi LY; Lai W; Xue RZ; Zhang XH; Chen RZ
    Chin Med J (Engl); 2010 Jul; 123(14):1909-14. PubMed ID: 20819577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal susceptibility testing: progress and future developments.
    Pfaller MA
    Braz J Infect Dis; 2000 Apr; 4(2):55-60. PubMed ID: 11012296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.
    Espinel-Ingroff A; Bartlett M; Chaturvedi V; Ghannoum M; Hazen KC; Pfaller MA; Rinaldi M; Walsh TJ
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1828-35. PubMed ID: 11353633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.